HETERO LABS LTD III FDA Approval ANDA 211732

ANDA 211732

HETERO LABS LTD III

FDA Drug Application

Application #211732

Application Sponsors

ANDA 211732HETERO LABS LTD III

Marketing Status

Over-the-counter001

Application Products

001TABLET, DELAYED RELEASE;ORALEQ 20MG BASE0OMEPRAZOLE MAGNESIUMOMEPRAZOLE MAGNESIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-03-25STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211732
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"OMEPRAZOLE MAGNESIUM","activeIngredients":"OMEPRAZOLE MAGNESIUM","strength":"EQ 20MG BASE","dosageForm":"TABLET, DELAYED RELEASE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/25\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-03-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.